Gastric Tumors Other than Adenocarcinoma and Lymphoma

  • N.C.T. Van Grieken
  • G.A. Meijer
  • E.J. Kuipers


In the previous chapters, gastric adenocarcinomas and lymphomas have been discussed. In addition to these two main tumor types, a variety of other gastric tumors are classified by the WHO according to their origin. These lesions are described in this chapter (Table 1).

Most tumorous lesions of the stomach are of epithelial origin. Among them, adenocarcinomas are the dominating tumor type. However, a variety of other epithelial and non-epithelial tumors can occur in the stomach, ranging from benign polyps with little tendency for malignant degeneration, such as fundic gland polyps, to malignant tumors such as carcinoids. In between, we find lesions with the potential for malignant degeneration like adenomas and (some) hyperplastic polyps. The aim of this chapter is to review epidemiological, pathogenetic, histological and clinical data for these less frequent epithelial and mesenchymal tumors of the stomach.


Small Cell Carcinoma Gastric Tumor Mesenchymal Tumor Hyperplastic Polyp Glomus Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol 2001; 116: 716–20PubMedCrossRefGoogle Scholar
  2. 2.
    Oberhuber G, Stolte M. Gastric polyps: an update of their pathology and biological significance. Virchows Arch 2000; 437: 581–90PubMedCrossRefGoogle Scholar
  3. 3.
    Wirtzfeld DA, Petrelli NJ, Rodriguez-Bigas MA. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol 2001; 8: 319–27PubMedCrossRefGoogle Scholar
  4. 4.
    Weiss SW, Goldblum JR. Ensinger and Weiss’s Soft tissue tumors 4th ed., Mosby Inc, St. Louis, 2001Google Scholar
  5. 5.
    Heinrich MC, Blanke CD, Druker BJ, Corless CL. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002; 20:1692–703PubMedCrossRefGoogle Scholar
  6. 6.
    Hamilton SR, Aaltonen LA (Eds.): World Health Organization Classification of Tumors. Pathology and genetics of tumors of the digestive system. IARC Press: Lyon 2000Google Scholar
  7. 7.
    Miettinen M, Lasota J. Gastrointestinal stromal tumors — definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001, 438:1–12PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • N.C.T. Van Grieken
    • 1
  • G.A. Meijer
    • 2
  • E.J. Kuipers
    • 3
  1. 1.Dpt. of GastroenterologyVU Medical CenterDe BoelelaanThe Netherlands
  2. 2.Dpt. of PathologyVU Medical CenterDe BoelelaanThe Netherlands
  3. 3.Department of Gastroenterology and HepatologyErasmus MC University Medical CenterNL-3062 PA RotterdamThe Netherlands

Personalised recommendations